{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:12:21Z","timestamp":1744949541967,"version":"3.40.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC No. 82272354"],"award-info":[{"award-number":["NSFC No. 82272354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11046-025-00936-8","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:37:32Z","timestamp":1740764252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antifungal Susceptibility of Melanized Fungi Isolated from CARD9 Deficient Patients: Implications for Treatment of Refractory Infections"],"prefix":"10.1007","volume":"190","author":[{"given":"Ying","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybren","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueke","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-6942","authenticated-orcid":false,"given":"Yinggai","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"936_CR1","unstructured":"de Hoog G.S, Guarro J, Gen\u00e9 J, Ahmed S, A.M.S. Al-Hatmi, Figueras MJ and Vitale RG. Atlas of clinical fungi. Available: https:\/\/www.atlasclinicalfungi.org\/"},{"key":"936_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.idc.2015.10.007","volume":"30","author":"EH Wong","year":"2016","unstructured":"Wong EH, Revankar SG. Dematiaceous molds. Infect Dis Clin North Am. 2016;30:165\u201378. https:\/\/doi.org\/10.1016\/j.idc.2015.10.007.","journal-title":"Infect Dis Clin North Am"},{"key":"936_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019570","volume":"5","author":"A Chowdhary","year":"2014","unstructured":"Chowdhary A, Perfect J, de Hoog GS. Black molds and melanized yeasts pathogenic to humans. Cold Spring Harb Perspect Med. 2014;5: a019570. https:\/\/doi.org\/10.1101\/cshperspect.a019570.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"936_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1128\/CMR.00019-10","volume":"23","author":"SG Revankar","year":"2010","unstructured":"Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010;23:884\u2013928. https:\/\/doi.org\/10.1128\/CMR.00019-10.","journal-title":"Clin Microbiol Rev"},{"key":"936_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005534","volume":"11","author":"R Agarwal","year":"2017","unstructured":"Agarwal R, Singh G, Ghosh A, Verma KK, Pandey M, Xess I. Chromoblastomycosis in India: review of 169 cases. PLoS Negl Trop Dis. 2017;11: e0005534. https:\/\/doi.org\/10.1371\/journal.pntd.0005534.","journal-title":"PLoS Negl Trop Dis"},{"key":"936_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1128\/CMR.00032-16","volume":"30","author":"F Queiroz-Telles","year":"2017","unstructured":"Queiroz-Telles F, de Hoog S, Santos DWCL, Salgado CG, Vicente VA, Bonifaz A, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30:233\u201376. https:\/\/doi.org\/10.1128\/CMR.00032-16.","journal-title":"Clin Microbiol Rev"},{"key":"936_CR7","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1111\/j.1439-0507.2010.01859.x","volume":"54","author":"D-M Li","year":"2011","unstructured":"Li D-M, Li R-Y, de Hoog GS, Sudhadham M, Wang D-L. Fatal exophiala infections in China, with a report of seven cases. Mycoses. 2011;54:e136-142. https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01859.x.","journal-title":"Mycoses"},{"key":"936_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/jof5030060","volume":"5","author":"J Velasco","year":"2019","unstructured":"Velasco J, Revankar S. CNS infections caused by brown-black Fungi. J Fungi (Basel). 2019;5:60. https:\/\/doi.org\/10.3390\/jof5030060.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"936_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1590\/abd1806-4841.20187321","volume":"93","author":"AC Brito","year":"2018","unstructured":"Brito AC, Bittencourt MJS. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update. An Bras Dermatol. 2018;93(4):495\u2013506. https:\/\/doi.org\/10.1590\/abd1806-4841.20187321.","journal-title":"An Bras Dermatol"},{"key":"936_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/myc.12853","volume":"62","author":"C Ferr\u00e1ndiz-Pulido","year":"2019","unstructured":"Ferr\u00e1ndiz-Pulido C, Martin-Gomez MT, Repiso T, Ju\u00e1rez-Dobjanschi C, Ferrer B, L\u00f3pez-Lerma I, et al. Cutaneous infections by dematiaceous opportunistic fungi: diagnosis and management in 11 solid organ transplant recipients. Mycoses. 2019;62:121\u20137. https:\/\/doi.org\/10.1111\/myc.12853.","journal-title":"Mycoses"},{"key":"936_CR11","doi-asserted-by":"publisher","first-page":"1021837","DOI":"10.3389\/fmicb.2022.1021837","volume":"13","author":"A Hu","year":"2022","unstructured":"Hu A, Hu Z, Zou H, Zhang J, Zhang D, Wang H, et al. CARD9 in host immunity to fungal, bacterial, viral, and parasitic infections: an update. Front Microbiol. 2022;13:1021837. https:\/\/doi.org\/10.3389\/fmicb.2022.1021837.","journal-title":"Front Microbiol"},{"key":"936_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaci.2013.09.033","volume":"133","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, et al. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. J Allergy Clin Immunol. 2014;133:905-908.e3. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.033.","journal-title":"J Allergy Clin Immunol"},{"key":"936_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jid.2017.10.009","volume":"138","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang R, Wu W, Song Y, Wan Z, Han W, et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol. 2018;138:607\u201317. https:\/\/doi.org\/10.1016\/j.jid.2017.10.009.","journal-title":"J Invest Dermatol"},{"key":"936_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11046-016-0029-0","volume":"181","author":"W Wu","year":"2016","unstructured":"Wu W, Zhang R, Wang X, Song Y, Liu Z, Han W, et al. Impairment of immune response against dematiaceous fungi in CARD9 knockout mice. Mycopathologia. 2016;181:631\u201342. https:\/\/doi.org\/10.1007\/s11046-016-0029-0.","journal-title":"Mycopathologia"},{"key":"936_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13693780802566333","volume":"47","author":"RG Vitale","year":"2009","unstructured":"Vitale RG, Perez-Blanco M, De Hoog GS. In vitro activity of antifungal drugs against cladophialophora species associated with human chromoblastomycosis. Med Mycol. 2009;47:35\u201340. https:\/\/doi.org\/10.1080\/13693780802566333.","journal-title":"Med Mycol"},{"key":"936_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802512451","author":"AW Fothergill","year":"2009","unstructured":"Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of exophiala spp: a head-to-head comparison of amphotericin B itraconazole posaconazole and voriconazole. Med Mycol. 2009. https:\/\/doi.org\/10.1080\/13693780802512451.","journal-title":"Med Mycol"},{"issue":"2","key":"936_CR17","first-page":"172","volume":"58","author":"TS de Andrade","year":"2020","unstructured":"de Andrade TS, de Almeida AMZ, Basano SDA, Takagi EH, Szeszs MW, Melhem MS, Camargo LMA. Chromoblastomycosis in the amazon region, Brazil, caused by fonsecaea pedrosoi, fonsecaea nubica, and rhinocladiella similis: clinicopathology, susceptibility, and molecular identification. Med Mycol. 2020;58(2):172\u201380.","journal-title":"Med Mycol"},{"key":"936_CR18","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1128\/JCM.02012-06","volume":"45","author":"JS Zeng","year":"2007","unstructured":"Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS. Spectrum of clinically relevant exophiala species in the United States. J Clin Microbiol. 2007;45:3713\u201320. https:\/\/doi.org\/10.1128\/JCM.02012-06.","journal-title":"J Clin Microbiol"},{"key":"936_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/myc.13556","volume":"66","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang Y, Ma Y, Wang Z, Wan Z, Song Y, et al. Challenges towards management of CARD9-deficient patients with phaeohyphomycosis: a case report and case series study. Mycoses. 2023;66:317\u201330. https:\/\/doi.org\/10.1111\/myc.13556.","journal-title":"Mycoses"},{"key":"936_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s10875-019-00662-z","volume":"39","author":"F Queiroz-Telles","year":"2019","unstructured":"Queiroz-Telles F, Mercier T, Maertens J, Sola CBS, Bonfim C, Lortholary O, et al. Successful allogenic stem cell transplantation in patients with inherited CARD9 deficiency. J Clin Immunol. 2019;39:462\u20139. https:\/\/doi.org\/10.1007\/s10875-019-00662-z.","journal-title":"J Clin Immunol"},{"key":"936_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/myc.12515","volume":"59","author":"G Bohelay","year":"2016","unstructured":"Bohelay G, Robert S, Bouges-Michel C, Gerin M, Levy A, Fain O, et al. Subcutaneous phaeohyphomycosis caused by exophiala spinifera in a European patient with lymphoma: a rare occurrence case report and literature review. Mycoses. 2016;59:691\u20136. https:\/\/doi.org\/10.1111\/myc.12515.","journal-title":"Mycoses"},{"key":"936_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/myc.12962","volume":"62","author":"C Huang","year":"2019","unstructured":"Huang C, Zhang Y, Song Y, Wan Z, Wang X, Li R. Phaeohyphomycosis caused by phialophora americana with CARD9 mutation and 20-year literature review in China. Mycoses. 2019;62:908\u201319. https:\/\/doi.org\/10.1111\/myc.12962.","journal-title":"Mycoses"},{"key":"936_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/1469-0691.12067","volume":"19","author":"Y-P Yang","year":"2013","unstructured":"Yang Y-P, Li W, Huang W-M, Zhou Y, Fan Y-M. Chromoblastomycosis caused by fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China. Clin Microbiol Infect. 2013;19:1023\u20138. https:\/\/doi.org\/10.1111\/1469-0691.12067.","journal-title":"Clin Microbiol Infect"},{"key":"936_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041512","author":"J Sun","year":"2012","unstructured":"Sun J, Najafzadeh MJ, Gerrits van den Ende AHG, Vicente VA, Feng P, Xi L, et al. Molecular characterization of pathogenic members of the genus fonsecaea using multilocus analysis. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0041512.","journal-title":"PLoS One"},{"key":"936_CR25","unstructured":"Clinical and Laboratory Standards Institute. 2017. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed. CLSI document M38-A3. Clinical and Laboratory Standards Institute, Wayne, PA; 2017"},{"key":"936_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1. https:\/\/doi.org\/10.1093\/jac\/dkg301.","journal-title":"J Antimicrob Chemother"},{"key":"936_CR27","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1128\/AAC.02526-15","volume":"60","author":"S Deng","year":"2016","unstructured":"Deng S, Pan W, Liao W, de Hoog GS, Gerrits van den Ende AHG, Vitale RG, et al. Combination of amphotericin B and flucytosine against neurotropic species of melanized fungi causing primary cerebral phaeohyphomycosis. Antimicrob Agents Chemother. 2016;60:2346\u201351.","journal-title":"Antimicrob Agents Chemother."},{"key":"936_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/myc.12779","volume":"61","author":"D G\u00fclmez","year":"2018","unstructured":"G\u00fclmez D, Do\u011fan \u00d6, Boral B, D\u00f6\u011fen A, \u0130lkit M, de Hoog GS, et al. In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature. Mycoses. 2018;61:561\u20139. https:\/\/doi.org\/10.1111\/myc.12779.","journal-title":"Mycoses"},{"key":"936_CR29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3389\/fimmu.2018.01836","volume":"9","author":"RA Drummond","year":"2018","unstructured":"Drummond RA, Franco LM, Lionakis MS. Human CARD9: a critical molecule of fungal immune surveillance. Front Immunol. 2018;9:1836. https:\/\/doi.org\/10.3389\/fimmu.2018.01836.","journal-title":"Front Immunol"},{"key":"936_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/infdis\/jiu412","volume":"211","author":"F Lanternier","year":"2015","unstructured":"Lanternier F, Barbati E, Meinzer U, Liu L, Pedergnana V, Migaud M, et al. Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection. J Infect Dis. 2015;211:1241\u201350. https:\/\/doi.org\/10.1093\/infdis\/jiu412.","journal-title":"J Infect Dis"},{"key":"936_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cmi.2021.06.012","volume":"28","author":"C Huang","year":"2022","unstructured":"Huang C, Liu B, Zhang Y, Song Y, Liu X, Wan Z, et al. Disseminated trichosporosis in a young patient with CARD9 deficiency. Clin Microbiol Infect. 2022;28:681\u20133. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.012.","journal-title":"Clin Microbiol Infect"},{"key":"936_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10875-020-00909-0","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Huang C, Song Y, Ma Y, Wan Z, Zhu X, et al. Primary cutaneous aspergillosis in a patient with CARD9 deficiency and aspergillus susceptibility of CARD9 knockout Mice. J Clin Immunol. 2021;41:427\u201340. https:\/\/doi.org\/10.1007\/s10875-020-00909-0.","journal-title":"J Clin Immunol"},{"key":"936_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jdermsci.2018.08.005","volume":"92","author":"W Wu","year":"2018","unstructured":"Wu W, Zhang R, Wang X, Song Y, Li R. Subcutaneous infection with dematiaceous fungi in CARD9 knockout mice reveals association of impair neutrophils and Th cell response. J Dermatol Sci. 2018;92:215\u20138. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.005.","journal-title":"J Dermatol Sci"},{"key":"936_CR34","doi-asserted-by":"publisher","first-page":"e00040","DOI":"10.1128\/IAI.00040-21","volume":"89","author":"L Sun","year":"2021","unstructured":"Sun L, Zhang S, Wan Z, Li R, Yu J. In vivo and in vitro impairments in T helper cell and neutrophil responses against mucor irregularis in CARD9 knockout mice. Infect Immun. 2021;89:e00040-e121. https:\/\/doi.org\/10.1128\/IAI.00040-21.","journal-title":"Infect Immun"},{"key":"936_CR35","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the American society for microbiology. Lancet Infect Dis. 2021;21:e246-57. https:\/\/doi.org\/10.1016\/S1473-3099(20)30784-2.","journal-title":"Lancet Infect Dis"},{"key":"936_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/myc.12895","volume":"62","author":"H Zheng","year":"2019","unstructured":"Zheng H, He Y, Kan S, Li D, Lv G, Shen Y, et al. In vitro susceptibility of dematiaceous fungi to nine antifungal agents determined by two different methods. Mycoses. 2019;62:384\u201390. https:\/\/doi.org\/10.1111\/myc.12895.","journal-title":"Mycoses"},{"key":"936_CR37","doi-asserted-by":"publisher","first-page":"e00643","DOI":"10.1128\/AAC.00643-20","volume":"64","author":"H Zheng","year":"2020","unstructured":"Zheng H, Song N, Mei H, Dong J, Li D, Li X, et al. In vitro activities of ravuconazole and isavuconazole against dematiaceous fungi. Antimicrob Agents Chemother. 2020;64:e00643-e720. https:\/\/doi.org\/10.1128\/AAC.00643-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"936_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/myc.12111","volume":"57","author":"TC Daboit","year":"2014","unstructured":"Daboit TC, Massotti Magagnin C, Heidrich D, Czekster Antochevis L, Vigolo S, Collares Meirelles L, et al. In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B. Mycoses. 2014;57:116\u201320. https:\/\/doi.org\/10.1111\/myc.12111.","journal-title":"Mycoses"},{"key":"936_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jgar.2018.09.010","volume":"16","author":"AH da Silva Hellwig","year":"2019","unstructured":"da Silva Hellwig AH, Heidrich D, Zanette RA, Scroferneker ML. In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: a systematic review. J Glob Antimicrob Resist. 2019;16:108\u201314. https:\/\/doi.org\/10.1016\/j.jgar.2018.09.010.","journal-title":"J Glob Antimicrob Resist"},{"key":"936_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.895329","volume":"12","author":"Y He","year":"2022","unstructured":"He Y, Zheng H-L, Mei H, Lv G-X, Liu W, Li X-F. Phaeohyphomycosis in China. Front Cell Infect Microbiol. 2022;12: 895329. https:\/\/doi.org\/10.3389\/fcimb.2022.895329.","journal-title":"Front Cell Infect Microbiol"},{"key":"936_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jof7010003","volume":"7","author":"LCD Breda","year":"2020","unstructured":"Breda LCD, Menezes IG, Paulo LNM, de Almeida SR. Immune sensing and potential immunotherapeutic approaches to control chromoblastomycosis. J Fungi (Basel). 2020;7:3. https:\/\/doi.org\/10.3390\/jof7010003.","journal-title":"J Fungi (Basel)"},{"key":"936_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41586-023-06710-4","volume":"623","author":"A Maji","year":"2023","unstructured":"Maji A, Soutar CP, Zhang J, Lewandowska A, Uno BE, Yan S, et al. Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal. Nature. 2023;623:1079\u201385. https:\/\/doi.org\/10.1038\/s41586-023-06710-4.","journal-title":"Nature"},{"key":"936_CR43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/jof8090963","volume":"8","author":"IS Sousa","year":"2022","unstructured":"Sousa IS, Mello TP, Pereira EP, Granato MQ, Alviano CS, Santos ALS, et al. Biofilm formation by chromoblastomycosis fungi Fonsecaea pedrosoi and Phialophora verrucosa: involvement with antifungal resistance. J Fungi (Basel). 2022;8:963. https:\/\/doi.org\/10.3390\/jof8090963.","journal-title":"J Fungi (Basel)"},{"key":"936_CR44","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/myc.13244","volume":"64","author":"Y Song","year":"2021","unstructured":"Song Y, Menezes da Silva N, Vicente VA, Quan Y, Teixeira M, Gong J, et al. Comparative genomics of opportunistic phialophora species involved in divergent disease types. Mycoses. 2021;64:555\u201368.","journal-title":"Mycoses."},{"key":"936_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966457","volume":"13","author":"Y Song","year":"2022","unstructured":"Song Y, Liu X, Stielow JB, de Hoog S, Li R. Post-translational changes in Phialophora verrucosa via lysine lactylation during prolonged presence in a patient with a CARD9-related immune disorder. Front Immunol. 2022;13: 966457. https:\/\/doi.org\/10.3389\/fimmu.2022.966457.","journal-title":"Front Immunol"},{"key":"936_CR46","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1128\/AAC.02875-14","volume":"58","author":"Y Li","year":"2014","unstructured":"Li Y, Wan Z, Li R. In vitro activities of nine antifungal drugs and their combinations against phialophora verrucosa. Antimicrob Agents Chemother. 2014;58:5609\u201312. https:\/\/doi.org\/10.1128\/AAC.02875-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"936_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2020.126668","volume":"244","author":"X Xiao","year":"2021","unstructured":"Xiao X, Li Y, Lan Y, Zhang J, He Y, Cai W, et al. Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus fonsecaea monophora. Microbiol Res. 2021;244: 126668. https:\/\/doi.org\/10.1016\/j.micres.2020.126668.","journal-title":"Microbiol Res"},{"key":"936_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006675","author":"RA Coelho","year":"2018","unstructured":"Coelho RA, Brito-Santos F, Figueiredo-Carvalho MHG, Silva JVDS, Gutierrez-Galhardo MC, do Valle ACF, et al. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp isolated from patients with chromoblastomycosis in Rio de Janeiro Brazil. PLoS Negl Trop Dis. 2018. https:\/\/doi.org\/10.1371\/journal.pntd.0006675.","journal-title":"PLoS Negl Trop Dis"},{"key":"936_CR49","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1128\/AAC.01655-09","volume":"54","author":"MJ Najafzadeh","year":"2010","unstructured":"Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, De Hoog GS, Meis JF. In vitro activities of eight antifungal drugs against 55 clinical isolates of fonsecaea spp. Antimicrob Agents Chemother. 2010;54:1636\u20138. https:\/\/doi.org\/10.1128\/AAC.01655-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"936_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.810604","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Sun J, Li M, Cai W, Chen Y, Liu Y, et al. Molecular characteristics of regional chromoblastomycosis in Guangdong, China: epidemiological, clinical, antifungal susceptibility, and serum cytokine profiles of 45 cases. Front Cell Infect Microbiol. 2022;12: 810604. https:\/\/doi.org\/10.3389\/fcimb.2022.810604.","journal-title":"Front Cell Infect Microbiol"},{"key":"936_CR51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11046-022-00628-7","volume":"187","author":"J Ling","year":"2022","unstructured":"Ling J, Pu Y, Gan J, Zhou W, Chen X, Zhang Q, et al. CARD9 deficiency in combination with invasive infection by exophiala dermatitidis in a pediatric patient. Mycopathologia. 2022;187:299\u2013303. https:\/\/doi.org\/10.1007\/s11046-022-00628-7.","journal-title":"Mycopathologia"},{"key":"936_CR52","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fneur.2019.00938","volume":"10","author":"C Wang","year":"2019","unstructured":"Wang C, Xing H, Jiang X, Zeng J, Liu Z, Chen J, et al. Cerebral phaeohyphomycosis caused by exophiala dermatitidis in a Chinese CARD9-deficient patient: a case report and literature review. Front Neurol. 2019;10:938. https:\/\/doi.org\/10.3389\/fneur.2019.00938.","journal-title":"Front Neurol"},{"key":"936_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11046-022-00623-y","volume":"187","author":"C Wu","year":"2022","unstructured":"Wu C, Shu L, Chen Z, Hu Q, Tao L, He C. Cutaneous phaeohyphomycosis of the right hand caused by exophiala jeanselmei: a case report and literature review. Mycopathologia. 2022;187:259\u201369. https:\/\/doi.org\/10.1007\/s11046-022-00623-y.","journal-title":"Mycopathologia"},{"key":"936_CR54","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/myc.13364","volume":"64","author":"MJ Najafzadeh","year":"2021","unstructured":"Najafzadeh MJ, Dolatabadi S, Vicente VA, de Hoog GS, Meis JF. In vitro activities of 8 antifungal drugs against 126 clinical and environmental exophiala isolates. Mycoses. 2021;64:1328\u201333. https:\/\/doi.org\/10.1111\/myc.13364.","journal-title":"Mycoses"},{"key":"936_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11046-010-9358-6","volume":"171","author":"Y Sun","year":"2011","unstructured":"Sun Y, Liu W, Wan Z, Wang X, Li R. Antifungal activity of antifungal drugs, as well as drug combinations against exophiala dermatitidis. Mycopathologia. 2011;171:111\u20137. https:\/\/doi.org\/10.1007\/s11046-010-9358-6.","journal-title":"Mycopathologia"},{"key":"936_CR56","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1128\/JCM.36.8.2353-2355.1998","volume":"36","author":"MR McGinnis","year":"1998","unstructured":"McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol. 1998;36:2353\u20135. https:\/\/doi.org\/10.1128\/JCM.36.8.2353-2355.1998.","journal-title":"J Clin Microbiol"},{"key":"936_CR57","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/13693786.2011.583285","volume":"49","author":"H Badali","year":"2011","unstructured":"Badali H, de Hoog GS, Sudhadham M, Meis JF. Microdilution in vitro antifungal susceptibility of exophiala dermatitidis, a systemic opportunist. Med Mycol. 2011;49:819\u201324. https:\/\/doi.org\/10.3109\/13693786.2011.583285.","journal-title":"Med Mycol"},{"key":"936_CR58","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JCM.02459-16","volume":"55","author":"AM Borman","year":"2017","unstructured":"Borman AM, Fraser M, Szekely A, Larcombe DE, Johnson EM. Rapid identification of clinically relevant members of the genus exophiala by matrix-assisted laser desorption ionization-time of flight mass spectrometry and description of two novel species, exophiala campbellii and exophiala lavatrina. J Clin Microbiol. 2017;55:1162\u201376. https:\/\/doi.org\/10.1128\/JCM.02459-16.","journal-title":"J Clin Microbiol"},{"key":"936_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/mmy.40.6.545.556","volume":"40","author":"RG Vitale","year":"2002","unstructured":"Vitale RG, de Hoog GS. Molecular diversity, new species and antifungal susceptibilities in the exophiala spinifera clade. Med Mycol. 2002;40:545\u201356. https:\/\/doi.org\/10.1080\/mmy.40.6.545.556.","journal-title":"Med Mycol"},{"key":"936_CR60","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/myc.13642","volume":"66","author":"X Zhu","year":"2023","unstructured":"Zhu X, Ma J, Zheng B, Cai W, Li J, Lin L, et al. Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by exophiala spinifera: a case report and literature review. Mycoses. 2023;66:1012\u20137. https:\/\/doi.org\/10.1111\/myc.13642.","journal-title":"Mycoses"},{"key":"936_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myab062","author":"A Guevara","year":"2021","unstructured":"Guevara A, Siqueira NP, Nery AF, Cavalcante LR, Hagen F, Hahn RC. Chromoblastomycosis in Latin America and the Caribbean: epidemiology over the past 50 years. Med Mycol. 2021. https:\/\/doi.org\/10.1093\/mmy\/myab062.","journal-title":"Med Mycol"},{"key":"936_CR62","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1128\/AAC.02114-12","volume":"57","author":"S Deng","year":"2013","unstructured":"Deng S, de Hoog GS, Badali H, Yang L, Najafzadeh MJ, Pan B, et al. In vitro antifungal susceptibility of cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrob Agents Chemother. 2013;57:1974\u20137. https:\/\/doi.org\/10.1128\/AAC.02114-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"936_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11046-020-00444-x","volume":"185","author":"J Qin","year":"2020","unstructured":"Qin J, Zhang J, Shi M, Xi L, Zhang J. Effect of Fonsecaea monophora on the polarization of THP-1 cells to macrophages. Mycopathologia. 2020;185:467\u201376. https:\/\/doi.org\/10.1007\/s11046-020-00444-x.","journal-title":"Mycopathologia"},{"key":"936_CR64","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11046-020-00429-w","volume":"185","author":"TFE Kimura","year":"2020","unstructured":"Kimura TFE, Romera LMD, de Almeida SR. Fonsecaea pedrosoi conidia induces activation of dendritic cells and increases CD11c+ cells in regional lymph nodes during experimental chromoblastomycosis. Mycopathologia. 2020;185:245\u201356. https:\/\/doi.org\/10.1007\/s11046-020-00429-w.","journal-title":"Mycopathologia"},{"key":"936_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01880","author":"Y Song","year":"2020","unstructured":"Song Y, Du M, Menezes da Silva N, Yang E, Vicente VA, Sybren de Hoog G, et al. Comparative analysis of clinical and environmental strains of exophiala spinifera by long-reads sequencing and RNAseq reveal adaptive strategies. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.01880.","journal-title":"Front Microbiol"},{"key":"936_CR66","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/pharmaceutics15071780","volume":"15","author":"JT Loh","year":"2023","unstructured":"Loh JT, Teo JKH, Kannan S, Verma CS, Lim H-H, Lam K-P. Disrupting the dok3-card9 interaction with synthetic peptides enhances antifungal effector functions of human neutrophils. Pharmaceutics. 2023;15:1780. https:\/\/doi.org\/10.3390\/pharmaceutics15071780.","journal-title":"Pharmaceutics"},{"issue":"1","key":"936_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.63049\/OHM.24.11.3","volume":"1","author":"T Sobianski Herman","year":"2024","unstructured":"Sobianski Herman T, Azevedo C, Bocca A, Lima B, Beato-Souza C, Razzolini E, et al. CARD9 mutations and T cell immune response in patients with chromoblastomycosis. One Health Mycol. 2024;1(1):14\u201322.","journal-title":"One Health Mycol."},{"key":"936_CR68","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02127-23","author":"X Niu","year":"2024","unstructured":"Niu X, Al-Hatmi AMS, Vitale RG, Lackner M, Ahmed SA, Verweij PE, et al. Evolutionary trends in antifungal resistance: a meta-analysis. Microbiol Spectr. 2024. https:\/\/doi.org\/10.1128\/spectrum.02127-23.","journal-title":"Microbiol Spectr"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-00936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-025-00936-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-00936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:16:01Z","timestamp":1744877761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-025-00936-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["936"],"URL":"https:\/\/doi.org\/10.1007\/s11046-025-00936-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"type":"print","value":"0301-486X"},{"type":"electronic","value":"1573-0832"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"The authors affirm that this material is original, has not been published in whole or in part elsewhere, and is not under consideration for publication in any other journal. Additionally, all authors have been personally and actively engaged in significant work contributing to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"29"}}